| 1 |
34031983 | Verapamil inhibits early acute liver failure through suppressing the NLRP3 inflammasome pathway. | 2021 May 24 |
1 |
| 2 |
32069862 | Protective Role of Shiitake Mushroom-Derived Exosome-Like Nanoparticles in D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice. | 2020 Feb 13 |
2 |
| 3 |
32701014 | Pterostilbene Protects Against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Upregulating the Nrf2 Pathway and Inhibiting NF-κB, MAPK, and NLRP3 Inflammasome Activation. | 2020 Sep |
1 |
| 4 |
33041005 | NLRP3 is dispensable for d-galactosamine/lipopolysaccharide-induced acute liver failure. | 2020 Dec 17 |
5 |
| 5 |
30597306 | Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways. | 2019 Mar |
1 |
| 6 |
30825154 | The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo. | 2019 |
1 |
| 7 |
30031824 | Daphnetin alleviates lipopolysaccharide/d-galactosamine-induced acute liver failure via the inhibition of NLRP3, MAPK and NF-κB, and the induction of autophagy. | 2018 Nov |
1 |
| 8 |
30197023 | AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. | 2018 Oct |
1 |
| 9 |
28709622 | Genipin protects d-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling. | 2017 Oct 5 |
1 |
| 10 |
23994575 | NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. | 2013 Dec |
8 |